Evogene Ltd.
EVGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,052 | -$3,529 | -$2,989 | -$5 |
| Dep. & Amort. | $281 | $290 | $579 | $593 |
| Deferred Tax | $0 | $1 | $0 | $7 |
| Stock-Based Comp. | $0 | $234 | $316 | $317 |
| Change in WC | -$467 | $986 | -$1,798 | -$572 |
| Other Non-Cash | $447 | -$5,501 | -$1,290 | -$5,547 |
| Operating Cash Flow | -$3,791 | -$2,301 | -$5,182 | -$5,207 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11 | -$2 | -$122 | -$322 |
| Net Acquisitions | $32 | $0 | $0 | $0 |
| Inv. Purchases | -$4,394 | $0 | -$2,326 | -$17,150 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $26,230 |
| Other Inv. Act. | $15,639 | -$987 | $2 | $0 |
| Investing Cash Flow | $11,267 | -$989 | -$2,446 | $8,758 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$137 | -$143 | -$206 |
| Stock Issued | $175 | $4,304 | $0 | $665 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$10,820 | -$18 | -$16 | -$19 |
| Financing Cash Flow | -$10,645 | $4,149 | -$159 | $440 |
| Forex Effect | $466 | $5,189 | -$19 | -$7 |
| Net Chg. in Cash | -$2,703 | $834 | -$7,806 | $3,984 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,329 | $7,495 | $15,301 | $11,317 |
| End Cash | $5,626 | $8,329 | $7,495 | $15,301 |
| Free Cash Flow | -$3,802 | -$2,303 | -$5,304 | -$5,529 |